Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).

Abstract

The purpose of the study was the comparison of the effect of the oral therapy of non-insulin-dependent diabetes mellitus (NIDDM) with either a sulphonylurea or biguanide derivative on plasma amylin level. In 10 healthy individuals the fasting plasma amylin level was 1.56 +/- 0.27 pmol/l (mean +/- SEM) and 6 min after i.v. injection of 1 mg glucagon a… (More)

Topics

Cite this paper

@article{ZapeckaDubno1999EffectOO, title={Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).}, author={B Zapecka-Dubno and Adam Czyżyk and Agata Dworak and M I Bak}, journal={Arzneimittel-Forschung}, year={1999}, volume={49 4}, pages={330-4} }